Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype

Expression of the human telomerase catalytic component, hTERT, in normal human somatic cells can reconstitute telomerase activity and extend their replicative lifespan. We report here that at twice the normal number of population doublings, telomerase-expressing human skin fibroblasts (BJ-hTERT) and retinal pigment epithelial cells (RPE-hTERT) retain normal growth control in response to serum deprivation, high cell density, G1 or G2 phase blockers and spindle inhibitors. In addition, we observed no cell growth in soft agar and detected no tumour formation in vivo. Thus, we find that telomerase expression in normal cells does not appear to induce changes associated with a malignant phenotype.

[1]  V. Freedman,et al.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. , 1974, Cell.

[2]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[3]  Benn Pa.  Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos. , 1976 .

[4]  J. Foidart,et al.  Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. , 1993, British Journal of Cancer.

[5]  W. W. Nichols,et al.  Karyotypic and phenotypic changes during in vitro aging of human endothelial cells , 1992, Journal of cellular physiology.

[6]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[7]  G. Wahl,et al.  p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. , 1998, Cancer research.

[8]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[9]  G. Wahl,et al.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.

[10]  R. DePinho,et al.  Essential role of mouse telomerase in highly proliferative organs , 1998, Nature.

[11]  K. Aldape,et al.  An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Tlsty,et al.  Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. , 1994, Genes & development.

[13]  C. Harley,et al.  Differential Expression of Telomerase Activity in Hematopoietic Progenitors from Adult Human Bone Marrow , 1996, Stem cells.

[14]  P. Moorhead,et al.  ANEUPLOIDY IN THE DEGENERATIVE PHASE OF SERIAL CULTIVATION OF HUMAN CELL STRAINS. , 1963, Proceedings of the National Academy of Sciences of the United States of America.

[15]  V. Freedman,et al.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[16]  V. Rotter,et al.  Role of wild type p53 in the G2 phase: regulation of the γirradiation-induced delay and DNA repair , 1997, Oncogene.

[17]  Gregg B. Morin,et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT , 1997, Nature Genetics.

[18]  G. Koch,et al.  Synchronization of HeLa cell cultures by inhibition of DNA polymerase alpha with aphidicolin. , 1980, Nucleic acids research.

[19]  Thea D. Tlsty,et al.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.

[20]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[21]  B. McKay,et al.  Separation of phenotypically distinct subpopulations of cultured human retinal pigment epithelial cells. , 1994, Experimental cell research.

[22]  P. Mullen,et al.  Effect of matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines , 1996 .

[23]  G. Hannon,et al.  Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.